Exon array analysis reveals neuroblastoma tumors have distinct alternative splicing patterns according to stage and MYCN amplification statusXiang Guo, Javed Khan, Qingrong Chen et al.|BMC Medical Genomics|2011Cited by 53
The BET bromodomain inhibitor exerts the most potent synergistic anticancer effects with quinone-containing compounds and anti-microtubule drugsPei Y. Liu, Tao Liu, Bernard Atmadibrata et al.|Oncotarget|2016Cited by 21